Establishes the "Missouri Environmental Exposure Early Cancer Detection Act"
HB 3528 establishes the “Missouri Environmental Exposure Early Cancer Detection Act” and creates a state-run pilot program for multicancer detection using liquid biopsy blood tests. The Department of Health and Senior Services would work with a qualified testing entity to design and implement the program, with a focus on voluntary screening for people in at-risk populations, including those living, attending school, or working in areas with documented environmental carcinogen exposure.
The bill defines key terms such as “liquid biopsy,” “at-risk populations,” and “testing entity,” and sets criteria for the outside health system that would partner with the state. That entity must have experience with precision medicine, use a test that screens for more than 50 cancers and includes signal-of-origin information, provide patient education, have a peer-review process for positive results, and support shared decision-making with patients. The program is intended to improve early cancer detection among people with prolonged toxic exposure, including residents near sites such as Coldwater Creek and Weldon Spring, and first responders, with firefighters given priority for assistance.
If enacted, the bill would add a new section to Chapter 192, RSMo, creating a new state health program and advisory structure within the Department of Health and Senior Services. It would require the General Assembly to appropriate funds for implementation, outreach, counseling, and testing costs, while also directing the department to seek federal grants and public-private partnerships. The bill would also require annual public reporting on participation, detection outcomes, stage at diagnosis, demographics, cost-effectiveness, and recommendations, and would establish an 11-member advisory council to oversee the pilot and help define at-risk populations.
The bill appears generally supportive of expanded cancer screening and environmental health protections, with an emphasis on helping communities exposed to toxic substances and improving early detection. Its framing around equity, outreach, and assistance for impacted residents and first responders suggests a public-health-oriented, preventive approach. No committee transcript or vote record is available in the provided materials, so there is no recorded formal opposition or support beyond the bill text itself.
The main policy questions likely concern the use of state funds for a pilot program, the reliability and clinical utility of multicancer liquid biopsy screening, and how at-risk populations should be defined. Potential points of debate also include whether the state should prioritize certain communities or occupations, such as residents near contaminated sites and firefighters, and whether the proposed testing entity and advisory council structure provide sufficient oversight. Because no hearing transcript or vote history is provided, specific named opponents or supporters cannot be identified from the record here.